Nestin as a diagnostic and prognostic marker: immunohistochemical analysis of its expression in different tumours

Por Ehrmann, J, Kolář, Z, Mokrý, J
Publicado em 2005

Relation of Bcl-2 expression to androgen receptor, p21WAF1/CIP1, and cyclin D1 status in prostate cancer

Por Kolář, Z, Murray, P G, Scott, K, Harrison, A, Vojtěšek, B, Dušek, J
Publicado em 2000

Nestin and collagen triple helix repeat containing 1 in breast cancer progression

Por Kharaishvili, G, Simkova, D, Cizkova, M, Bouchalova, K, Mgebrishvili, G, Kolar, Z, Bouchal, J
Publicado em 2011

Differences in p53 and Bcl-2 expression in relation to cell proliferation during the development of human embryos.

Por Lichnovský, V, Kolár, Z, Murray, P, Hlobilková, A, Cernochová, D, Pospísilová, E, Vojtĕsek, B, Nenutil, R
Publicado em 1998

Synthetic inhibitors of CDKs induce different responses in androgen sensitive and androgen insensitive prostatic cancer cell lines

Por Mad’arová, J, Lukešová, M, Hlobilková, A, Strnad, M, Vojtěšek, B, Lenobel, R, Hajdúch, M, Murray, P G, Perera, S, Kolář, Z
Publicado em 2002

BCL2 is a predictive marker of adjuvant CMF regimen in triple-negative breast cancer patients

Por Bouchalova, K, Cizkova, M, Trojanec, R, Koudelakova, V, Radova, L, Furstova, J, Melichar, B, Cwiertka, K, Kharaishvili, G, Kolar, Z, Hajduch, M
Publicado em 2011

Expression of the matrix metalloproteinase 9 in Hodgkin's disease is independent of EBV status

Por Flavell, J R, Baumforth, K R N, Williams, D M, Lukesova, M, Madarova, J, Noskova, V, Prochazkova, J, Lowe, D, Kolar, Z, Murray, P G, Nelson, P N
Publicado em 2000